JP2004519475A5 - - Google Patents

Download PDF

Info

Publication number
JP2004519475A5
JP2004519475A5 JP2002567137A JP2002567137A JP2004519475A5 JP 2004519475 A5 JP2004519475 A5 JP 2004519475A5 JP 2002567137 A JP2002567137 A JP 2002567137A JP 2002567137 A JP2002567137 A JP 2002567137A JP 2004519475 A5 JP2004519475 A5 JP 2004519475A5
Authority
JP
Japan
Prior art keywords
interferon
pharmaceutical composition
composition according
antibody
antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002567137A
Other languages
English (en)
Japanese (ja)
Other versions
JP4394350B2 (ja
JP2004519475A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/000343 external-priority patent/WO2002067760A2/en
Publication of JP2004519475A publication Critical patent/JP2004519475A/ja
Publication of JP2004519475A5 publication Critical patent/JP2004519475A5/ja
Application granted granted Critical
Publication of JP4394350B2 publication Critical patent/JP4394350B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002567137A 2001-01-09 2002-01-08 対象における自己免疫疾患の治療法及びｉｎｖｉｔｒｏ診断アッセイ Expired - Fee Related JP4394350B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26054101P 2001-01-09 2001-01-09
PCT/US2002/000343 WO2002067760A2 (en) 2001-01-09 2002-01-08 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009063336A Division JP2009132736A (ja) 2001-01-09 2009-03-16 対象における自己免疫疾患の治療法及びｉｎｖｉｔｒｏ診断アッセイ

Publications (3)

Publication Number Publication Date
JP2004519475A JP2004519475A (ja) 2004-07-02
JP2004519475A5 true JP2004519475A5 (https=) 2007-05-10
JP4394350B2 JP4394350B2 (ja) 2010-01-06

Family

ID=22989575

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002567137A Expired - Fee Related JP4394350B2 (ja) 2001-01-09 2002-01-08 対象における自己免疫疾患の治療法及びｉｎｖｉｔｒｏ診断アッセイ
JP2009063336A Withdrawn JP2009132736A (ja) 2001-01-09 2009-03-16 対象における自己免疫疾患の治療法及びｉｎｖｉｔｒｏ診断アッセイ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009063336A Withdrawn JP2009132736A (ja) 2001-01-09 2009-03-16 対象における自己免疫疾患の治療法及びｉｎｖｉｔｒｏ診断アッセイ

Country Status (14)

Country Link
US (3) US20020160974A1 (https=)
EP (2) EP1351707B9 (https=)
JP (2) JP4394350B2 (https=)
KR (1) KR100951409B1 (https=)
CN (2) CN100536919C (https=)
AT (1) ATE502648T1 (https=)
AU (1) AU2002246955B2 (https=)
BR (1) BR0206364A (https=)
CA (1) CA2433806C (https=)
DE (1) DE60239522D1 (https=)
DK (1) DK1351707T3 (https=)
ES (1) ES2363761T3 (https=)
MX (1) MXPA03006100A (https=)
WO (1) WO2002067760A2 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1351707B9 (en) * 2001-01-09 2012-01-25 Baylor Research Institute Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
EP1701736A4 (en) * 2003-12-24 2008-05-07 Inst Medical W & E Hall THERAPEUTIC AGENTS AND USES
US7662381B2 (en) 2004-06-21 2010-02-16 Medarex, Inc. Interferon alpha receptor 1 antibodies and their uses
CN103251953A (zh) * 2004-07-19 2013-08-21 约翰·霍普金斯大学 供免疫抑制的flt3抑制剂
CN101056654A (zh) * 2004-10-07 2007-10-17 苏黎士大学 用于预防和治疗银屑病的i型干扰素阻断剂
CN101155831B (zh) * 2005-02-10 2015-08-19 贝勒研究院 抗干扰素α单克隆抗体及其使用方法
US7888481B2 (en) * 2005-02-10 2011-02-15 Baylor Research Institute Anti-interferon alpha monoclonal antibodies and methods for use
CA2686861A1 (en) * 2007-05-03 2008-11-13 Medimmune, Llc Interferon alpha-induced pharmacodynamic markers
MX340916B (es) 2008-01-18 2016-07-29 President And Fellows Of Harvard College * Metodos para detectar señales de identificacion de enfermedad o condiciones en fluidos corporales.
KR20160070165A (ko) 2008-02-08 2016-06-17 메디뮨 엘엘씨 Ｆｃ 리간드 친화성이 감소된 항-ＩＦＮＡＲ１ 항체
CN102083859B (zh) 2008-05-07 2014-09-17 阿哥斯医疗公司 人源化抗人干扰素-α抗体
EP2353004B1 (en) 2008-11-12 2018-01-03 Yeda Research and Development Co. Ltd. Diagnosis of multiple sclerosis
CN101812119B (zh) * 2009-02-25 2012-02-01 上海荣盛生物药业有限公司 与免疫抗体相结合的多肽及其应用
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
US20130203624A1 (en) 2010-07-23 2013-08-08 President And Fellows Of Harvard College Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
TW201209171A (en) 2010-07-23 2012-03-01 Harvard College Methods of detecting diseases or conditions using phagocytic cells
CN103384824B (zh) * 2010-12-06 2016-02-03 Thd股份公司 癌症诊断方法及其用途
US9823246B2 (en) 2011-12-28 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University Fluorescence enhancing plasmonic nanoscopic gold films and assays based thereon
DE13746292T1 (de) * 2012-02-10 2014-10-30 Hakushinkouseikai Foundation Proliferationsmittel für monozyten, kulturmedium zur proliferation von monozyten, verfahren zur herstellung von monozyten, verfahren zur herstellung dendritischer zellen und verfahren zur herstellung eines impfstoffs mit dendritischen zellen
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
KR101536697B1 (ko) * 2013-11-29 2015-07-14 아주대학교산학협력단 베체트병 진단용 조성물
US10626464B2 (en) 2014-09-11 2020-04-21 Cell Mdx, Llc Methods of detecting prostate cancer
US20160146799A1 (en) 2014-11-05 2016-05-26 Nirmidas Biotech, Inc. Metal composites for enhanced imaging
CA3029627A1 (en) 2016-07-01 2018-01-04 Resolve Therapeutics, Llc Optimized binuclease fusions and methods
CA3073537A1 (en) 2017-08-22 2019-02-28 Sanabio, Llc Soluble interferon receptors and uses thereof
KR20250139415A (ko) * 2018-02-14 2025-09-23 호라이즌 테라퓨틱스 아일랜드 디에이씨 고양이 맥도너 육종(fms)-유사 티로신 키나제 3 수용체 리간드(flt3l)에 대한 항체 및 자가면역 및 염증 질환을 치료하기 위한 이의 용도
US12123881B2 (en) * 2018-04-20 2024-10-22 Unm Rainforest Innovations Rap1-Gtp, Rac1-GTP and FMS-like tyrosine kinase 3 ligand (FLT3-L) as biomarkers for early detection of sepsis
WO2019241158A1 (en) * 2018-06-11 2019-12-19 Univerity Of Washington Compositions and methods for treating inflammatory diseases
CN113238061B (zh) * 2021-07-09 2021-10-01 中南大学湘雅医院 以cd180阴性b细胞指示重症肌无力病情的试剂盒及应用
CN115032396B (zh) * 2022-06-29 2025-02-21 深圳市康尔诺生物技术有限公司 一种用于预测或判断受试者的肿瘤免疫治疗效果的生物标志物及其应用
CN115678982A (zh) * 2022-09-09 2023-02-03 中山大学 一种用于慢性自身免疫病诊断和/或病种判断的试剂盒
AR130792A1 (es) * 2022-10-20 2025-01-22 Glaxosmithkline Intellectual Property No 3 Ltd Proteínas de unión a antígeno
WO2025015182A2 (en) * 2023-07-12 2025-01-16 New York Society For The Relief Of The Ruptured And Crippled, Maintaining The Hospital For Special Surgery Compositions and methods for treatment of autoimmunity

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423147A (en) * 1980-04-11 1983-12-27 Secher David S Monoclonal antibody to interferon-α
GR81946B (https=) * 1980-09-25 1984-12-12 Genentech Inc
US4456748A (en) * 1981-02-23 1984-06-26 Genentech, Inc. Hybrid human leukocyte interferons
US4414150A (en) * 1980-11-10 1983-11-08 Genentech, Inc. Hybrid human leukocyte interferons
US4362155A (en) * 1981-03-24 1982-12-07 Skurkovich Simon V Method and apparatus for the treatment of autoimmune and allergic diseases
US4605394A (en) * 1982-12-03 1986-08-12 Simon V. Skurkovich Methods for the treatment of pathological conditions by removing interferon from the organism
US4824432A (en) * 1981-03-24 1989-04-25 S.V.S. Laboratories, Inc. Method for treating AIDS and other immune deficiencies and immune disorders
DE3211263A1 (de) * 1981-03-31 1983-01-27 Otsuka Pharmaceutical Co. Ltd., Tokyo Human-interferon verwandte peptide, antigene und antikoerper, sowie verfahren zu deren herstellung
US4678751A (en) * 1981-09-25 1987-07-07 Genentech, Inc. Hybrid human leukocyte interferons
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
US5096705A (en) * 1981-10-19 1992-03-17 Genentech, Inc. Human immune interferon
US5827694A (en) * 1982-03-08 1998-10-27 Genentech, Inc. DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
US5831023A (en) * 1982-11-01 1998-11-03 Genentech, Inc. Recombinant animal interferon polypeptides
US4534906A (en) * 1982-11-01 1985-08-13 Genentech, Inc. Removal of impurities from human leukocyte interferon preparations
EP0139676B1 (en) * 1983-02-04 1992-11-25 Cytoclonal Pharmaceutics Inc. Production and characterization of hybridoma antibodies directed specifically against common determinant(s) present among closely related, but distinct proteins
GB2148299B (en) * 1983-09-01 1988-01-06 Hybritech Inc Antibody compositions of therapeutic agents having an extended serum half-life
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
US5082658A (en) * 1984-01-16 1992-01-21 Genentech, Inc. Gamma interferon-interleukin-2 synergism
FR2560212B1 (fr) * 1984-02-24 1989-12-29 Unicet Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
US4650674A (en) * 1984-07-05 1987-03-17 Genentech, Inc. Synergistic cytotoxic composition
US5196323A (en) * 1985-04-27 1993-03-23 Boehringer Ingelheim International Gmbh Process for preparing and purifying alpha-interferon
US4828830A (en) * 1986-01-24 1989-05-09 Genentech, Inc. Method and composition for prophylaxis and treatment of viral infections
JPS6330426A (ja) * 1986-07-25 1988-02-09 Mitsubishi Chem Ind Ltd 自己免疫性疾患治療薬
US4851219A (en) * 1986-11-18 1989-07-25 Genentech, Inc. Method for the treatment of chronic myelogenous leukemia
US4987071A (en) * 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US4944941A (en) * 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
US5254678A (en) * 1987-12-15 1993-10-19 Gene Shears Pty. Limited Ribozymes
AU2844889A (en) 1988-01-22 1989-07-27 Collagen Corporation Method for suppressing the growth of normal and cancer cells
CA1340323C (en) 1988-09-20 1999-01-19 Arnold E. Hampel Rna catalyst for cleaving specific rna sequences
US5168053A (en) * 1989-03-24 1992-12-01 Yale University Cleavage of targeted RNA by RNAase P
US5889151A (en) * 1989-10-20 1999-03-30 Societe Leb-Tech Purified human alpha interferon receptor
US5919452A (en) * 1991-03-18 1999-07-06 New York University Methods of treating TNFα-mediated disease using chimeric anti-TNF antibodies
ES2133285T3 (es) * 1991-04-17 1999-09-16 Medisup Int Nv Polipeptidos hidrosolubles que tienen una alta afinidad para los interferones alfa y beta.
US5227158A (en) * 1991-06-10 1993-07-13 Genentech, Inc. Method of stimulating hepatocyte proliferation by administration of hepatocyte growth factor and gamma-interferon
DK0601052T3 (da) * 1991-08-30 1996-11-18 Genentech Inc Terapeutisk fremgangsmåde til behandling af IDDM
US5248499A (en) * 1991-10-07 1993-09-28 Genentech, Inc. Control of microbial infections in transplant patients
EP0563487A1 (en) * 1992-03-31 1993-10-06 Laboratoire Europeen De Biotechnologie S.A. Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
US5821078A (en) * 1992-09-03 1998-10-13 Yeda Research And Development Co. Ltd. Nucleic acid encoding interferon-α/β binding protein
US5888511A (en) * 1993-02-26 1999-03-30 Advanced Biotherapy Concepts, Inc. Treatment of autoimmune diseases, including AIDS
CZ307995A3 (en) 1993-05-24 1996-10-16 Immunex Corp Ligands for flt3 receptors
US5554512A (en) 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US6630143B1 (en) * 1993-05-24 2003-10-07 Immunex Corporation Antibodies against flt3 ligand
EP0725654A1 (en) * 1993-09-17 1996-08-14 Laboratoire Europeen De Biotechnologie S.A. Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
US5959085A (en) * 1993-11-23 1999-09-28 Schering Corporation Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
US5780027A (en) * 1995-07-14 1998-07-14 Meiogen Biotechnology Corporation Methods of treatment of down syndrome by interferon antagonists
IL118096A0 (en) 1996-05-01 1996-09-12 Yeda Res & Dev Antibodies against interferon alpha/beta receptor
US6713609B1 (en) * 1996-07-16 2004-03-30 Genentech, Inc. Monoclonal antibodies to type I interferon receptor
US5859183A (en) * 1997-02-13 1999-01-12 The Rockefeller University Altered telomere repeat binding factor
US20030018174A1 (en) * 1997-10-06 2003-01-23 Genentech, Inc. Monoclonal antibodies to IFNAR2
DE69840739D1 (de) * 1997-10-27 2009-05-28 Merix Bioscience Inc Methode und Zusammensetzung zur Herstellung von reifen dendritischen Zellen
EP1037995A1 (en) * 1997-12-08 2000-09-27 Genentech, Inc. Human interferon-epsilon: a type 1 interferon
ZA9811070B (en) * 1997-12-08 2000-07-03 Genentech Inc Type I interferons.
US6291661B1 (en) * 1998-07-02 2001-09-18 Immunex Corporation flt3-L mutants and method of use
US6673908B1 (en) * 1999-02-22 2004-01-06 Nuvelo, Inc. Tumor necrosis factor receptor 2
AU784361C (en) 1999-12-30 2007-03-15 Imclone Systems Incorporated Progenitor cell preservation factors and related methods and products
GB0001710D0 (en) * 2000-01-25 2000-03-15 Pharma Pacific Pty Ltd Therapeutic treatment
US6846486B1 (en) * 2000-02-24 2005-01-25 Advanced Biotherapy Concepts, Inc. Method of treating allergy by administering an anti-histamine antibody
US6660523B2 (en) * 2000-09-21 2003-12-09 Schering Corporation Dendritic cells; methods
EP1351707B9 (en) * 2001-01-09 2012-01-25 Baylor Research Institute Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
US7087726B2 (en) * 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies
FR2822845B1 (fr) * 2001-03-30 2003-12-12 Genodyssee Nouveaux polynucleotides comportant des polymorphismes de type snp fonctionnels dans la sequence nucleotidique du gene ifn-alpha-21 ainsi que de nouveaux polypeptides codes par ces polynucleotides et leurs utilisations therapeutiques
US6554512B2 (en) * 2001-04-26 2003-04-29 Zih Corp. Printer for printing deformable flat supports and its loader
JP2007525458A (ja) 2003-04-23 2007-09-06 メダレックス インコーポレイテッド インターフェロンα受容体−１（ＩＦＮＡＲ−１）に対するヒト化抗体
KR101225299B1 (ko) * 2003-12-10 2013-01-24 메다렉스, 인코포레이티드 인터페론 알파 항체 및 그의 용도
CN101056654A (zh) 2004-10-07 2007-10-17 苏黎士大学 用于预防和治疗银屑病的i型干扰素阻断剂

Similar Documents

Publication Publication Date Title
JP2004519475A5 (https=)
CA2433806A1 (en) Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
Saschenbrecker et al. Serological diagnosis of autoimmune bullous skin diseases
Wadhwa et al. Strategies for detection, measurement and characterization of unwanted antibodies induced by therapeutic biologicals
Tahara et al. A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders
Corti et al. Tumor Necrosis Factor (TNF) α quantification by ELISA and bioassay: Effects of TNFα-soluble TNF receptor (p55) complex dissociation during assay incubations
Porta et al. Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma
Suh et al. Approaches for the detection and analysis of antidrug antibodies to biopharmaceuticals: A review
JP2013163673A5 (https=)
CA2434512A1 (en) Marker for inflammatory conditions
Kasum et al. Importance of macroprolactinemia in hyperprolactinemia
RU2011118477A (ru) Способы и композиции для диагностики и лечения аутоиммунной болезни, возникающей вследствие рассеянного склероза
Thorpe et al. Current methods for detecting antibodies against erythropoietin and other recombinant proteins
Castagna et al. Hepcidin assay in serum by SELDI-TOF-MS and other approaches
Kakkar et al. Population PK and IgE pharmacodynamic analysis of a fully human monoclonal antibody against IL4 receptor
Thorpe et al. Assays for detecting and diagnosing antibody-mediated pure red cell aplasia (PRCA): an assessment of available procedures
Torres et al. Hypersensitivity reactions to beta-lactams
Meager et al. Detection of anti-cytokine antibodies and their clinical relevance
Liparoto et al. Biosensor analysis of the interleukin‐2 receptor complex
WO2003098185A2 (en) Systems and methods for identifying organ transplant risk
US9927443B2 (en) Risk assessment for therapeutic drugs
JP2022545312A (ja) 関節リウマチの診断及び処置の方法
Groome et al. Enzyme immunoassays for inhibins, activins and follistatins
US20060003384A1 (en) Detection of measurement of antibodies to antigenic proteins in biological tissues or samples
Myler et al. Biotherapeutic bioanalysis: a multi-indication case study review